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Trends
Members of the Nox/Duox NADPH oxi-
dase family produce ROS in a regu-
lated manner in several different cells
and tissues.
Pharmacological inhibition of non-pha-
gocytic Nox/Duox enzymes might have
therapeutic potential.
Several studies have described the dis-
ease-modifying phenotypes of Nox1
and Nox4 knockouts.
The lack of Nox4-derived ROS can lead
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Nox/Duox NADPH oxidases are now considered the primary, regulated sources
of reactive oxygen species (ROS). These enzymes are expressed in diverse cells
and tissues, and their products are essential in several physiological settings.
Knockout mouse models are instrumental in identifying the physiological func-
tions of Nox/Duox enzymes as well as in exploring the impact of their pharma-
cological targeting on disease progression. The currently available data from
experiments on knockout animals suggest that the lack of non-phagocytic Nox/
Duox enzymes often modiﬁes the course and phenotype in many disease
models. Nevertheless, as illustrated by studies on Nox4-deﬁcient animals,
the absence of Nox-derived ROS can also lead to aggravated disease manifes-
tation, reinforcing the need for amore balanced view on the role of ROS in health
and disease.to aggravated disease development,
which is in contrast to the prevailing
dogma that considers ROS to be gen-
erally harmful.
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(M. Geiszt).NADPH Oxidases
Members of the Nox/Duox family NADPH oxidases are the primary sources of regulated ROS
production in a wide range of organisms (Box 1) [1–3]. Once thought to be an exclusive feature of
phagocytes, ROS production by NADPH oxidases has now also been described in several
different tissues and cells [1]. There are seven members of the Nox/Duox enzyme family in
humans: Nox1–5, Duox1, and Duox2 [4] (Figure 1). Intriguingly, mice and rats lack the Nox5
isoform. Nox/Duox enzymes have been implicated in a vast array of biological settings including
host defense, vasoregulation, hormone synthesis, fertilization, cell proliferation, cell differentia-
tion, and extracellular matrix formation [1,3].
It is generally accepted that homeostasis normally ensures tight regulation of ROS levels since
the highly reactive molecules can easily inﬂict damage on cellular constituents. By contrast,
deﬁcient production of ROS may also have deleterious consequences as illustrated by the
serious clinical picture of chronic granulomatous disease, in which phagocytic superoxide
production is practically absent [5], or by congenital hypothyroidism caused by Duox2 deﬁciency
[6]. Considering the widespread expression of non-phagocytic Nox/Duox enzymes, and their
presence in vital organs, it is reasonable to believe that altered activity of other Nox/Duox
enzymes can also contribute to disease pathogenesis (Table 1). In cases where the pathogenic
role of certain Nox/Duox isoforms is caused by increased activity, pharmacological inhibition
may have therapeutic potential [7]. However, to obtain a fair assessment of the feasibility of
therapeutic Nox inhibition, the physiological functions of different isoforms should be identiﬁed.
To this end, the phenotypic analysis of knockout animals may provide information about the
physiological functions of speciﬁc NADPH oxidase isoforms. Studying disease development and
progression in knockout animals also offers the possibility of uncovering the role of Nox enzymesTrends in Pharmacological Sciences, Month Year, Vol. xx, No. yy http://dx.doi.org/10.1016/j.tips.2016.01.006 1
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Box 1. NADPH Oxidases
The story of NADPH oxidases stems from phagocyte research. When exposed to foreign pathogens, phagocytic cells –
such as neutrophil granulocytes – produce large amounts of superoxide. Superoxide and its derivatives (ROS) have a
crucial role in the killing of the invading pathogens. ROS act like a ‘double-edged sword’, meaning that they are essential
for killing pathogens; however, they can also be harmful to host tissues. In phagocytic cells, superoxide (O2
–) is produced
by the NADPH oxidase enzyme, which transfers electrons from NADPH tomolecular oxygen. The ‘core’ of this enzyme is
a heme-binding, ﬂavoprotein Nox2 (formerly known as gp91phox), which catalyzes the ﬁnal steps of electron transfer. It
was known for some time that besides phagocytes, other types of mammalian cells synthesize and release ROS, which
can serve various biological functions. However, the enzymatic background of non-phagocytic ROS production was
unknown. Beginning from 1999, several enzymes were identiﬁed at the molecular level, which are now proven to be
responsible for regulated ROS production observed in diverse tissues. These proteins are highly homologous to the
phagocytic NADPH oxidase and are now designated the Nox/Duox family of NADPH oxidases. The Nox family of NADPH
oxidases consists of the following members: Nox1, Nox2, Nox3, Nox4, Nox5, Duox1, and Duox2. The discovery of this
enzyme family has stimulated ROS research since we can now assign a speciﬁc source of ROS in several tissues,
including the gastrointestinal tract, kidney, heart, lung, thyroid, inner ear, and blood vessels.in disease pathogenesis. This latter experimental approach is particularly important in the
process of drug target identiﬁcation. Genetic models of Nox/Duox deﬁciency are also crucial
tools when expression of these enzymes is examined at the protein level, as using knockout
samples in western blot or immunostaining experiments is the ultimate control to prove the
speciﬁcity of an antibody. In this review, we discuss the results of studies involving mouse
models with Nox/Duox deﬁciency. The complex host defense problem that develops in
the absence of a functional phagocytic oxidase and the role of Nox2 in other disease models
have been covered in several papers [1,5,8], therefore they are not discussed in this work. Since
non-phagocytic Nox/Duox isoforms are expressed in various cells and tissues, this review
necessarily includes the discussion of ﬁndings from seemingly unrelated experimental models.
Even so, the results discussed here are connected in a way that they all reﬂect the consequences
of the absence of Nox/Duox-derived ROS.
Nox1
Nox1 was the ﬁrst homolog of Nox2 (formerly known as gp91phox [1_TD$DIFF]) to be identiﬁed [9]. Nox1 is
highly expressed in the colon (Figure 1), where it localizes to epithelial cells. Similar to its
phagocytic counterpart, Nox1 functions in a complex with p22phox [10]. To form a superox-
ide-producing enzyme complex, Nox1 requires two additional proteins, NOXO1 and NOXA1,
which are also present in the colon epithelium [11]. Nox1-deﬁcient mice were ﬁrst created by
Matsuno et al., who described no obvious abnormality of the animals [12].
In spite of the fact that the colon has the highest level of Nox1 expression, surprisingly little is
known about the function of Nox1 in this organ. The colon is normally inhabited by a huge
number of bacteria; thus, the presence of Nox1 and its regulators in the colon, along with the
homology between the phagocytic and colon oxidases suggest a role in host defense. However,
disturbed antimicrobial function in Nox1 knockout animals has not yet been reported. Coant
et al. showed that progenitor cells in the colon of Nox1 knockout mice are converted into goblet
cells in higher numbers than that in wild-type animals [13]. The increase in goblet cell number
was paralleled by the reduced number of colonocytes. Cell fate in the colon is controlled by Wnt
and Notch1 signaling, and ROS produced by the colon oxidase may inﬂuence these pathways
through the redox regulation of PTEN and NF-kB [13]. Recent data suggest that bacteria may
have a signiﬁcant role in controlling cell proliferation in the colon through Nox1. Jones et al. have
shown that Lactobacilli stimulate ROS production and proliferation of intestinal epithelial cells in a
Nox1-dependent manner [14]. ROS production by the colon oxidase might also contribute to
mucosal repair after injury. In an intestinal epithelial-speciﬁc Nox1 knockout model, mucosal
healing was impaired in Nox1 knockouts [15]. This deﬁciency is likely explained by a previously
unknown signaling pathway, in which the activity of Nox1 is regulated by an endogenous
N-formyl peptide receptor ligand, annexin 1. Nox1-derived ROS then stimulate epithelial cell2 Trends in Pharmacological Sciences, Month Year, Vol. xx, No. yy
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Figure 1. Characteristic Expression of Nox/Duox Isoforms. For each Nox/Duox protein the ﬁrst organ where its
expression was originally reported – and where it also shows an accordingly high expression level – is displayed. Nox1 in the
colon, Nox2 in phagocytes, Nox3 in the inner ear, Nox4 in renal epithelial cells, Nox5 in the spleen and testis, and Duox 1 and
Duox2 in the thyroid gland. For a detailed description of the expression pattern of each isoform, refer to review articles [1–3].migration and wound repair through the oxidative inactivation of protein phosphatases PTEN
and PTP-PEST [15]. Several lines of evidence suggest that ROS contribute to the development
of inﬂammatory bowel disease [16,17]. In this regard, a potential role of Nox1 is particularly
interesting since the enzyme is located in the colon epithelial cells themselves while previously
only inﬂammatory cells were considered as a ROS source. Glutathione peroxidase-1 and -2
double knockout mice develop spontaneous ileocolitis, the severity of which is dependent on the
genetic background. When these mice were crossed with Nox1 knockout animals, the severity
of the colitis was reduced, thus proving a role for Nox1-derived ROS in the inﬂammatory process
[18]. In contrast to this ﬁnding, the absence of Nox1 in IL-10-deﬁcient animals induced intestinal
inﬂammation, which is probably caused by endoplasmic reticulum stress, developing in double
knockout goblet cells [19].
The expression of Nox1 is not restricted to the colon epithelium, as the enzyme has been
described in several other cell types, including vascular smooth muscle cells [9]. Angiotensin IITrends in Pharmacological Sciences, Month Year, Vol. xx, No. yy 3
TIPS 1307 No. of Pages 10
Table 1. Mouse Models of Non-Phagocytic Nox/Duox Deﬁciency
Gene Genotype Predicted or Proved Change in Pro-
tein Expression
Gross Phenotype
Nox1 [12,20] 1. Exons 3–6 deleted [12,20]
2. Exon 13 truncated [15] (Cre/
lox-based)
Predicted loss of protein [12,20],
predicted truncated protein [15]
None observed
Nox3 [30] Spontaneous mutations:
Line hetR96: 441 (T ! A)
Line het2J: 1282 (G ! A)
Line hetR542: 1576 (A ! G)
Line hetR96: a 147 amino acid long
truncated protein, early STOP after
third transmembrane domain
Line het2J: 428. Conserved Gly! Arg
change in the NADPH binding site
Line hetR542: 526. Lys ! Gln change
in putative NADPH binding site
Balance defect
(head tilt)
Nox4 [28,36,40] 1. Exons 1–2 deleted [36] (Cre/
lox-based)
2. Exon 4 deleted [45]
2. Exons 14–15 deleted [28]
3. Exon 9 deleted [40] (Cre/lox-
based)
Proved loss of protein None observed
Duox1 [67] Trapping cassette inserted
between exons 20 and 21
Proved loss of protein None observed
Duox2 [54] Spontaneous mutation:
2021 (T ! G)
674. Val ! Gly change after the ﬁrst
transmembrane helix, reduced
protein expression, and loss of ROS
production [55]
Congenital
hypothyroidism
p22phox [32] Spontaneous mutation:
361 (T ! C)
121. Tyr! His change in the second
transmembrane domain, proved loss
of protein
Balance defect
Noxo1 [31] Spontaneous mutation: A
(deoxyadenosine) insertion in
exon 1 after the 28th
nucleotide
Frameshift after the ninth amino acid
that yields a 34 amino acid long
truncated protein
Balance defect
(head slant)
Noxa1 [33] Deletion of exons 3–6 (Cre/lox-
based)
Frameshift after the 88th amino acid,
then incorporation of 19 novel amino
acids before the premature stop
codon, predicted loss of protein
None observed
DuoxA1/
DuoxA2 [56]
Simultaneous deletion of exons
after the exon 5 in both DuoxA
genes
246 amino acid long truncated
DuoxA1, 232 amino acid long
truncated DuoxA2, predicted loss of
activators
Congenital
hypothyroidisminfusion induces increased blood pressure in mice, and this response is attenuated in the genetic
absence of Nox1 [12,20]. One study reported decreased basal blood pressure in Nox1
knockout animals [20], while another group did not ﬁnd such a difference [12]. The absence
of Nox1 might be protective against angiotensin II-induced hypertension because the lack of
superoxide increases the bioavailability of nitric oxide. Matsuno et al. found that vascular
hypertrophy stimulated by angiotensin II was unchanged in the absence of Nox1 [12], while
Gavazzi et al. reported reduced aorta hypertrophy, characterized by decreased accumulation of
extracellular matrix [20]. In Nox1 knockout animals, angiotensin II-elicited aortic dissection is less
severe, and this protective effect is unlikely due to lower blood pressure since norepinephrine
treatment induces hypertension but fails to induce dissections in wild-type or Nox1 knockout
mice [21]. In angiotensin II-infused Nox1 knockout animals, the expression level of tissue inhibitor
of metalloproteinase 1 (TIMP-1) is increased when compared with wild-type mice. The elevation
of TIMP-1 level in the vascular wall can reduce the activity of matrix metalloproteinases (MMPs),4 Trends in Pharmacological Sciences, Month Year, Vol. xx, No. yy
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transgenicmodel of hypertension, where active human renin is produced under the control of the
transthyretin promoter, deletion of Nox1 did not reduce blood pressure, while oxidative stress
was less prominent in the knockouts [22]. There is also evidence that oxidative stress elicited by
hyperglycemia in endothelial cells is mediated by Nox1 [23]. Furthermore, in an experimental
model of diabetes mellitus, ApoE-deﬁcient mice develop less severe atherosclerosis when the
nox1 gene is also disrupted [23].
Nox1 mRNA is also present in neurons, although the expression has never been demonstrated
at the protein level. We also know little about the expression of NOXO1 and NOXA1 in neurons.
This is an important problem since the mere demonstration of Nox1 mRNA expression does not
necessarily prove that a Nox1-based oxidase complex is active in the cell.
Nox1mRNA expression was detected in dorsal root ganglion (DRG) neurons and Nox1-deﬁcient
animals show attenuated response to inﬂammatory pain [24]. Chemical mediators of inﬂamma-
tory pain augment the capsaicin-induced calcium signal through the activation of TRPV1
channel, and this regulatory effect was found to be altered in Nox1 knockouts. The same
group reported that in the absence of Nox1 the analgesic effect of morphine was potentiated,
and analgesic tolerance was suppressed [25]. Further experiments that include an attempt to
identify each component of the Nox1-based oxidase complex in DRG neurons are clearly
needed before we can appreciate the physiological signiﬁcance of the above-discussed
observations.
Working with the same Nox1-deﬁcient mouse line, conﬂicting results have been published about
the role of Nox1 in the development of ischemic injury of the brain. Kahles et al. observed a
signiﬁcant reduction of infarct size at 24 h following a 1 h ischemic period implemented by the
occlusion of the middle cerebral artery (MCAO) [26]. The beneﬁcial effect of Nox1 deletion no
longer existed if the occlusion lasted 2 h or longer. In a similar study, Jackman et al. applied
MCAO for only 0.5 h and analyzed the injury also after 24 h [27]. They found no difference in total
infarct volume; however, a 4-fold greater cortical infarct volume was observed in Nox1 knock-
outs, suggesting that the activity of Nox1 could be protective in the cortex. In contrast to these
studies, Kleinschnitz et al. reported no difference in lesion size and functional outcome between
wild-type and Nox1 knockout animals [28].
Nox1 is also expressed in microglia, where Nox2 appears to be the other dominant Nox isoform
[29]. When lipopolysaccharide (LPS) was injected into the striatum of Nox1 knockouts and wild-
type animals, nitrotyrosine formation was reduced in the knockouts, implicating Nox1 in the
formation of peroxynitrite. This activity may inﬂict damage on neurons since in the LPS-injected
region of Nox1 knockouts, a reduced loss of synapsin (a marker of presynaptic terminals) was
detected [29].
Nox3
Among NADPH oxidases, Nox3 seems to have the most restricted expression pattern in the
mammalian organism. Nox3 is speciﬁcally localized to the inner ear (Figure 1), where it is required
for the proper development of otoconia crystals of the vestibular system. This unique function of
Nox3 was ﬁrst revealed by successful positional cloning of several mutant mouse alleles at the
head tilt (het) locus on chromosome 17 [30]. Mutations at this locus lead to severe balance and
spatial orientation defects of adult mice. All these mutants caused loss of function of the nox3
gene [30].
The speciﬁc role of Nox3 in vestibular development was further corroborated by a study identifying
an NADPH oxidase organizer 1 (Noxo1) mutation responsible for the head slant (hslt) mouseTrends in Pharmacological Sciences, Month Year, Vol. xx, No. yy 5
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in the hsltmice were also severely disturbed, while other morphological structures of the inner ear
seemed to be normal [31]. In agreement with these results, another indispensable component of
the functioning Nox3 complex, p22phox, was also shown to be necessary for otoconia formation
[32]. The nmf333 mutant mouse strain carries missense mutation in the transmembrane region
eliminating the expression of the p22phox protein [32]. A special staining method (von Kossa)
showed the lack of calcium carbonate crystals in the utriculus just like in the case of the Nox3-
deﬁcient head tilt animals. Along with the balance defects, the nmf333 animals also have severe
immunodeﬁciency due to the lack of phagocyte oxidase (Nox2) activity [32].
Although Noxo1 and Noxa1 were shown to interact in the Nox1 complex of colon epithelial cells
[11], Noxa1 knockouts do not show balance defects, indicating that Noxa1 is not part of the
inner ear NADPH oxidase complex [33].
Nox4
Nox4 was ﬁrst identiﬁed in kidney epithelial cells [34] (Figure 1), but in the past 10 years the
enzyme has been identiﬁed in several different cell types, including endothelial cells, vascular
smoothmuscle, ﬁbroblasts, cardiomyocytes, skeletal muscle, osteoclasts, adipocytes, neurons,
and microglia [1]. Although Nox4 is currently the most extensively studied Nox isoform,
surprisingly few knockout studies have been published on Nox4. Research on this Nox isoform
has been hampered by the lack of speciﬁc antibodies that can detect endogenously expressed
protein [35]. Accordingly, the intracellular localization of Nox4 is still unclear and the protein was
described at several intracellular locations including the nucleus, endoplasmic reticulum, focal
adhesions, plasma membrane, and mitochondria.
In the mouse kidney, Nox4 is mainly expressed in proximal tubules although its mRNA was also
detected in other segments of the nephron, including glomeruli and medullary collecting ducts
[34]. It is of note that Nox4-deﬁcient animals show no gross abnormality in their kidneys [28,36].
Babelova et al. studied the course of three different chronic kidney disease models in mice with
global or inducible Nox4 deletion [37]. Models included diabetes-induced kidney injury, unilateral
ureter ligation, and 5/6 nephrectomy, respectively. The absence of Nox4 was not protective in
either of the models, and the course of ﬁbrosis induced by unilateral ureter obstruction was even
slightly more severe in Nox4-deﬁcient animals [37]. An independent study, using the samemodel
of kidney ﬁbrosis in a different Nox4-deﬁcient strain, yielded similar results – the absence of Nox4
was found to be associated with more severe interstitial ﬁbrosis [38]. Further analysis of the
Nox4-deﬁcient kidney revealed that the absence of the enzyme increased the apoptotic rate of
tubular cells and reduced vascularization [38]. The lower interstitial capillary density was
probably a consequence of decreased HIF-1/ expression. Interestingly, in ApoE-deﬁcient mice
the absence of Nox4 offered protection against glomerular damage in diabetic nephropathy [39].
Hopefully in the future, Nox4 knockouts will also assist to elucidate the physiological role of
Nox4 in the kidney. The high expression level in proximal tubular cells along with the constitutive
ROS-producing activity suggest a yet to be identiﬁed physiological function for the enzyme.
Nox4 is also present in the heart, where its precise expression pattern remains to be determined.
Zhang et al. studied the role of Nox4 in cardiac adaptation to pressure overload using Nox4
knockouts and transgenic animals that overexpressed Nox4 in a cardiac-speciﬁc manner [36].
Their results suggest that Nox4 has a protective role in chronic load-induced stress [36]. The
signaling pathways behind the protective effect of Nox4 include higher induction of HIF-1/
resulting in elevated vascular endothelial growth factor (VEGF) levels and enhanced angiogene-
sis [36]. This study was the ﬁrst to demonstrate that the absence of Nox4 might have deleterious
consequences. Interestingly, in mice where Nox4 was deleted in a cardiomyocyte-speciﬁc6 Trends in Pharmacological Sciences, Month Year, Vol. xx, No. yy
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suggesting a pathogenic role for Nox4 [40]. Further studies should clarify the reason for these
conﬂicting ﬁndings; however, it should be mentioned that a more severe pressure overload was
induced in the latter study. It is also important to note that results obtained with cell-speciﬁc
knockouts could be misleading when the function of an organ is analyzed as a whole. As for the
heart, three different cell types in the heart (cardiomyocytes, endothelial cells, ﬁbroblasts) were
described to express Nox4 [41]. Consequently, deletion of Nox4 activity in a cardiomyocyte-
speciﬁc manner does not ensure a complete loss of Nox4 activity in the organ.
Endothelial cells are a particularly rich source of Nox4 and the enzyme seems to have a
protective role in blood vessels [42]. In response to ischemia, the formation of new blood
vessels was found to be lowered in Nox4-deﬁcient animals and angiotensin II-induced vascular
dysfunction was also more severe in Nox4 knockouts. Loss of Nox4 activity was accompanied
by reduced expression of endothelial nitric oxide synthase (eNOS) and heme oxygenase leading
to decreased formation of protective endothelial mediators [42]. In a recent study, accelerated
atherosclerosis was found in Nox4 knockout animals [43] that might be explained by reduced
leukocyte adhesion to Nox4-deﬁcient endothelial cells. Overexpression of Nox4 in an endothe-
lium-speciﬁc manner reduces atherosclerosis in ApoE–/– mice, an observation that also points to
an anti-atherosclerotic effect of Nox4-derived ROS [44].
Nox4 is also expressed in the lung, where type II epithelial cells and endothelial cells contain the
enzyme. In a bleomycin-induced ﬁbrosis model, the lungs of Nox4 knockout mice showed less
severe pathological changes than that of wild-type animals [45]. The protective effect of Nox4
deﬁciency was probably due to the reduced apoptotic rate of type II epithelial cells. A previous
study, using RNA interference, already suggested that Nox4 might be important in the devel-
opment of lung ﬁbrosis. That study, however, implicated reduced formation of myoﬁbroblasts as
an explanation for the protective effect of Nox4 deﬁciency [46].
The possible role of ROS in the pathogenesis of neurodegenerative diseases is currently a
subject of intense research, and thus elucidating the function of Nox4 in the central nervous
system (CNS) is also of great interest. In an ischemic stroke model induced by transient MCAO,
Nox4-deﬁcient mice developed less oxidative stress and were protected from brain damage
[28]. In immunostaining experiments, the authors detected an induction of Nox4 in neurons,
although Nox4 knockouts were not included as negative controls [28]. VAS2870, a non-speciﬁc
inhibitor of Nox enzymes mimicked the effect of genetic Nox4 deletion, raising hopes for the
development of an anti-stroke therapeutic strategy using Nox inhibitors. Experiments on Nox4
knockout animals revealed that the enzyme is also present in a subset of DRG neurons, where it
has a role in nociceptive processing [47]. Although Nox4 was identiﬁed in nonmyelinated
neurons, Nox4-mediated ROS production induced dysmyelination of a different ﬁber population
in a mouse model of peripheral nerve injury.
Osteoclasts are among the cell types where Nox4 was ﬁrst described [48]. Nox4 knockout
animals have higher bone density, a phenotype that is likely caused by impaired formation and
activation of osteoclasts [49]. In a murine model of postmenopausal osteoporosis, pharmaco-
logical or genetic inhibition of Nox4 reduced the loss of trabecular bone [49].
Duox1 and Duox2
Duox1 and Duox2 were ﬁrst cloned from porcine and human thyroid gland (Figure 1) [50,51]. For
proper targeting and function, Duox enzymesmust interact with Duox activator proteins DuoxA1
and DuoxA2 [52]. Homozygous nonsensemutation in Duox2 causing congenital hypothyroidism
demonstrated its obligate function in thyroid hormone biosynthesis [6,53]. Mice with a sponta-
neously developed missense Duox2 mutation develop the phenotype characteristic forTrends in Pharmacological Sciences, Month Year, Vol. xx, No. yy 7
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Outstanding Questions
In sharp contrast to the pathology of
Nox3 and Duox2 deﬁciencies, the
absence of Nox1, Nox4, or Duox1
does not result in an obvious pheno-
type and knockout models for these
genes did not help uncover their roles
in organs where they were originally
discovered. Thus, we still do not know:
What is the physiological function of
Nox1 in the colon?
What is the role of Nox4 in kidney epi-
thelial cells?
What is the function of epithelial-
expressed Duox1 in different organs,
including the thyroid?
What is the physiological role of Duox2
outside of the thyroid?
What is the function of Nox5? The
absence of Nox5 in mice and rats calls
for developing animal models of other
species.congenital hypothyroidism [54] due to the loss of Duox2-mediated ROS production [55].
Simultaneous knockout of the two genes encoding DuoxA1 and DuoxA2 led to the development
of the same phenotype [56].
Duoxexpression is not conﬁned to the thyroid gland; the enzyme ispresent onmucosal surfaces of
the respiratory and gastrointestinal tract, where a host defense function was suggested [57].
According to the model introduced by Geiszt et al., Duox-produced H2O2 supports lactoperox-
idase to generate hypothiocyanite, which is an effective antimicrobial compound against a broad
range of bacteria [58–60]. In non-vertebrates, such as Drosophila, zebraﬁsh, and Caenorhabditis
elegans, a growing cluster of data supports the indispensable role of Duox in gastrointestinal
control of commensal, foodborne, or pathogenicmicroorganisms [61–63]. Recently, an interesting
study on DuoxA double knockout mice conﬁrmed the protective role of Duox2-derived H2O2, as it
prevented the gastric colonization by Helicobacter felis and attendant inﬂammatory responses
[64]. This study was the ﬁrst in vivo genetic demonstration in a mammalian organism of how Duox
can control the colonization of a noninvasive pathogen of the mucus layer. The innate immune
modulatory effect of Duox-derived H2O2 was further conﬁrmed by a recent study in an ovalbumin-
inducedallergic asthmamodel using theDuox1-andDuox2-deﬁcientDuoxA–/–double knockouts,
where reduced mucus cell metaplasia, decreased airway resistance, and lower level of Th2
cytokine secretion was found in the DuoxA–/– mice [65]. In a separate study, ﬂagellin-stimulated
expression of inﬂammation and immune response-related genes was attenuated in the nasal
mucosaof theDuox2-deﬁcientmicecomparedwithwild-typeanimals [66]. Importantly, in the latter
study Duox2 knockout animals were not hormone-supplemented, thus the profound effect of
thyroid hormone deﬁciency on gene expression should also be considered. Since precise
restoration of physiological thyroid hormone levels is probably difﬁcult to achieve, conditional
knockouts lacking Duox2 in a tissue-speciﬁc manner will be instrumental in the assessment of
Duox2 function in mucosal host defense. Another interesting question is whether the speciﬁc
deletion of Duox2 in colon epithelial cells affects the expression and function of Nox1, which is also
highly expressed in the colon. It is possible that the twoenzymeshave someoverlapping functions,
although the differences in their regulation may be a sign of distinct biological functions. Never-
theless, the presence of two different Nox/Duox isoforms in colon epithelial cells highlights the
importance of regulated ROS production in the colon.
Duox1 is also expressed in the thyroid gland, although its function remains unknown. Functional
redundancy in hormone synthesis is unlikely since Duox1 cannot substitute for the loss of
Duox2, and Duox1 knockout mice are not hypothyroid [67]. We detected Duox1 expression in
mouse urothelium and showed in in vivo cystometry experiments using knockout mice that
Duox1-derived H2O2 attenuates urinary bladder contractions [67]. We propose that mechanical
stretch of the bladder urothelium triggers Duox1 activation, but further studies are needed to
elucidate whether H2O2 acts directly or in a paracrine manner, diffusing to neighboring cells and
acting on smooth muscle or nerve cells.
Concluding Remarks
There are several approaches to study the function of a particular gene. Although the use of
pharmacological inhibitors, and more recently RNA interference, offer a quick way to assess
gene function in cell culture or in vivo, it is important to keep in mind that speciﬁcity of these
approaches is often insufﬁcient. The creation of inheritable mutation in mice offers a more
speciﬁc way to study gene function. Although the generation of knockout mouse models was
generally time-consuming, recently discovered gene-modifying techniques have dramatically
reduced the time needed for gene targeting [68]. Knockout mice models are now available for all
mammalian Noxs and their regulators, except for Nox5, which is not expressed in mice.
Experiments on gene-deﬁcient animals have helped to understand the physiological function
of Nox3 and conﬁrmed the essential role of Duox2 in thyroid hormone synthesis. In the case of8 Trends in Pharmacological Sciences, Month Year, Vol. xx, No. yy
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expressed at their highest levels (see Outstanding Questions). This is a major concern when
considering the pharmacological targeting of these isoforms, because unexpected side effects
may result from the inhibition. Several studies have documented the disease-modifying phe-
notypes of Nox1 and Nox4 knockouts, and in some cases the results suggest that pharmaco-
logical inhibition of their activity might have therapeutic value. However, several observations that
document the deleterious effects of Nox gene deletion on disease progression offer the
provocative conclusion that devising pharmacological tools to stimulate their activity would
sometimes be more desirable.
The discovery of the Nox/Duox family of NADPH oxidases has dramatically transformed our view
of ROS and oxidative stress. The fact that diverse cells and tissues express Nox/Duox enzymes
proves that regulated production of ROS is an integral part of maintaining homeostasis. Thus,
the traditional dogma that considered ROS as exclusively harmful substances is no longer
acceptable and is gradually replaced by a more differentiated view on their role in physiology and
pathophysiology. Hopefully, future experiments using Nox/Duox-deﬁcient knockouts will help
us to better comprehend their physiological functions and clarify the therapeutic potential of
Nox/Duox inhibition.
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